BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1551314)

  • 1. Increased hypothalamic neuropeptide Y messenger RNA levels in two rat models of diabetes.
    Jones PM; Pierson AM; Williams G; Ghatei MA; Bloom SR
    Diabet Med; 1992; 9(1):76-80. PubMed ID: 1551314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated neuropeptide Y concentrations in the central hypothalamus of the spontaneously diabetic BB/E Wistar rat.
    Williams G; Lee YC; Ghatei MA; Cardoso HM; Ball JA; Bone AJ; Baird JD; Bloom SR
    Diabet Med; 1989; 6(7):601-7. PubMed ID: 2527701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of streptozotocin-induced diabetes mellitus and insulin treatment on neuropeptide Y mRNA in the rat hypothalamus.
    Marks JL; Waite K; Li M
    Diabetologia; 1993 Jun; 36(6):497-502. PubMed ID: 8335171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats.
    White JD; Olchovsky D; Kershaw M; Berelowitz M
    Endocrinology; 1990 Feb; 126(2):765-72. PubMed ID: 2404748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of neuropeptide Y in glucose sensing in the dorsal hypothalamus of streptozotocin diabetic rats - in vitro and in vivo studies of transmitter release.
    Gozali M; Pavia JM; Morris MJ
    Diabetologia; 2002 Sep; 45(9):1332-9. PubMed ID: 12242467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased hypothalamic neuropeptide Y concentration or hyperphagia in streptozotocin-diabetic rats are not mediated by glucocorticoids.
    Dryden S; Burns SJ; Frankish HM; Williams G
    Eur J Pharmacol; 1997 Dec; 340(2-3):221-5. PubMed ID: 9537819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoleptinemia, but not hypoinsulinemia, induces hyperphagia in streptozotocin-induced diabetic rats.
    Hidaka S; Yoshimatsu H; Kondou S; Oka K; Tsuruta Y; Sakino H; Itateyama E; Noguchi H; Himeno K; Okamoto K; Teshima Y; Okeda T; Sakata T
    J Neurochem; 2001 May; 77(4):993-1000. PubMed ID: 11359864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of diabetic hyperphagia in neuropeptide Y--deficient mice.
    Sindelar DK; Mystkowski P; Marsh DJ; Palmiter RD; Schwartz MW
    Diabetes; 2002 Mar; 51(3):778-83. PubMed ID: 11872679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease of hypothalamic neuropeptide Y gene expression by vanadyl sulfate in streptozotocin-induced diabetic rats.
    Liu IM; Chi TC; Cheng JT
    Horm Metab Res; 2001 Feb; 33(2):96-100. PubMed ID: 11294500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of neuropeptide Y and its mRNA in STZ-diabetic rats.
    Fu M; Li X; Zhang M; Xian Y
    Chin Med J (Engl); 2002 May; 115(5):690-5. PubMed ID: 12133536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy.
    Sahu A; Sninsky CA; Kalra PS; Kalra SP
    Endocrinology; 1990 Jan; 126(1):192-8. PubMed ID: 2136723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression.
    Sipols AJ; Baskin DG; Schwartz MW
    Diabetes; 1995 Feb; 44(2):147-51. PubMed ID: 7859932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting regulates hypothalamic neuropeptide Y, agouti-related peptide, and proopiomelanocortin in diabetic mice independent of changes in leptin or insulin.
    Mizuno TM; Makimura H; Silverstein J; Roberts JL; Lopingco T; Mobbs CV
    Endocrinology; 1999 Oct; 140(10):4551-7. PubMed ID: 10499510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic vagotomy alters limbic and hypothalamic neuropeptide responses to insulin-dependent diabetes and voluntary lard ingestion.
    la Fleur SE; Manalo SL; Roy M; Houshyar H; Dallman MF
    Eur J Neurosci; 2005 May; 21(10):2733-42. PubMed ID: 15926921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of glucocorticoids in mediating effects of fasting and diabetes on hypothalamic gene expression.
    Makimura H; Mizuno TM; Isoda F; Beasley J; Silverstein JH; Mobbs CV
    BMC Physiol; 2003 Jul; 3():5. PubMed ID: 12848900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a high-fat diet on food intake and hypothalamic neuropeptide gene expression in streptozotocin diabetes.
    Chavez M; Seeley RJ; Havel PJ; Friedman MI; Matson CA; Woods SC; Schwartz MW
    J Clin Invest; 1998 Jul; 102(2):340-6. PubMed ID: 9664075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats.
    Havel PJ; Hahn TM; Sindelar DK; Baskin DG; Dallman MF; Weigle DS; Schwartz MW
    Diabetes; 2000 Feb; 49(2):244-52. PubMed ID: 10868941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased neuropeptide Y content in the arcuato-paraventricular hypothalamic neuronal system in both insulin-dependent and non-insulin-dependent diabetic rats.
    Abe M; Saito M; Ikeda H; Shimazu T
    Brain Res; 1991 Jan; 539(2):223-7. PubMed ID: 2054597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y system mRNA expression changes in the hippocampus of a type I diabetes rat model.
    Campos EJ; Martins J; Brudzewsky D; Woldbye DPD; Ambrósio AF
    Ann Anat; 2020 Jan; 227():151419. PubMed ID: 31563570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ghrelin in streptozotocin-induced diabetic hyperphagia.
    Ishii S; Kamegai J; Tamura H; Shimizu T; Sugihara H; Oikawa S
    Endocrinology; 2002 Dec; 143(12):4934-7. PubMed ID: 12446621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.